Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia.

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · see citing works

Memory - A century of consolidation

McGaugh, J. L. (2000) · Science · doi:10.1126/science.287.5451.248 · Cited by 4,250 · see citing works

Deep Brain Stimulation for Treatment-Resistant Depression

Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059 · see citing works

A Neurotrophic Model for Stress-Related Mood Disorders

Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · see citing works

Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus

Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111 · see citing works

Subgenual prefrontal cortex abnormalities in mood disorders

Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693 · see citing works

A molecular and cellular theory of depression

Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129 · see citing works

Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation

Chen, R., Classen, J., Gerloff, C., Celnik, P., Wassermann, E. M., Hallett, M., & Cohen, L. G. (1997) · Neurology · doi:10.1212/wnl.48.5.1398 · Cited by 2,128 · cited 4× · see citing works

Hippocampal atrophy in recurrent major depression

Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932 · see citing works

Context, time, and memory retrieval in the interference paradigms of Pavlovian learning

Bouton, M. E. (1993) · Psychological Bulletin · doi:10.1037/0033-2909.114.1.80 · Cited by 1,896 · see citing works

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

Göttlicher, M., Minucci, S., Zhu, P., Krämer, O. H., Schimpf, A., Giavara, S., Sleeman, J. P., Coco, F. L., Nervi, C., Pelicci, P. G., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,889 · see citing works

Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms

Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795 · see citing works

Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action

Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780 · see citing works

Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen

Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758 · see citing works

Hippocampal volume and depression: a meta-analysis of MRI studies

Videbech, P., & Ravnkilde, B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1957 · Cited by 1,590 · see citing works

Glial reduction in the subgenual prefrontal cortex in mood disorders

Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525 · see citing works

Neurogenesis in the Dentate Gyrus of the Adult Tree Shrew Is Regulated by Psychosocial Stress and NMDA Receptor Activation

Gould, E., McEwen, B. S., Tanapat, P., Galea, L. A. M., & Fuchs, E. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-07-02492.1997 · Cited by 1,496 · see citing works

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗∗See accompanying Editorial, in this issue.

Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477 · see citing works

Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies

Vanderschuren, L. J. M. J., & Kalivas, P. W. (2000) · Psychopharmacology · doi:10.1007/s002130000493 · Cited by 1,337 · see citing works

A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression

Keller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., Markowitz, J. C., Nemeroff, C. B., Russell, J. M., Thase, M. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422001 · Cited by 1,331 · see citing works

Fear conditioning induces associative long-term potentiation in the amygdala

Rogan, M. T., Stäubli, U. V., & LeDoux, J. E. (1997) · Nature · doi:10.1038/37601 · Cited by 1,310 · see citing works

Mechanisms of fear extinction

Myers, K. M., & Davis, M. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001939 · Cited by 1,277 · see citing works

Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications

Sen, S., Duman, R., & Sanacora, G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.005 · Cited by 1,232 · see citing works

Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging

Sapolsky, R., Krey, L., & McEwen, B. (1985) · The Journal of Neuroscience · doi:10.1523/jneurosci.05-05-01222.1985 · Cited by 1,129 · see citing works

A Guide to Treatments that Work

Nathan, P. E., & Gorman, J. M. (2007) · Oxford University Press eBooks · doi:10.1093/med/9780195304145.001.0001 · Cited by 1,082 · see citing works

Cognitive Enhancers as Adjuncts to Psychotherapy: Use of D-Cycloserine in Phobic Individuals to Facilitate Extinctionof Fear

Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., & Davis, M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1136 · Cited by 1,063 · see citing works

Stress-Induced Alterations in Prefrontal Cortical Dendritic Morphology Predict Selective Impairments in Perceptual Attentional Set-Shifting

Liston, C., Miller, M. M., Goldwater, D. S., Radley, J. J., Rocher, A. B., Hof, P. R., Morrison, J. H., & McEwen, B. S. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1184-06.2006 · Cited by 968 · see citing works

Pilot study of secondary prevention of posttraumatic stress disorder with propranolol

Pitman, R. K., Sanders, K. M., Zusman, R. M., Healy, A. R., Cheema, F., Lasko, N. B., Cahill, L., & Orr, S. P. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01279-3 · Cited by 964 · see citing works

Cognitive-Behavioral Therapy, Imipramine, or Their Combination for Panic Disorder: A Randomized Controlled Trial

Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000) · JAMA · doi:10.1001/jama.283.19.2529 · Cited by 953 · see citing works

A functional neuroanatomy of hallucinations in schizophrenia

Silbersweig, D. A., Stern, E., Frith, C., Cahill, C., Holmes, A., Grootoonk, S., Seaward, J., McKenna, P., Chua, S. E., Schnorr, L., et al. (1995) · Nature · doi:10.1038/378176a0 · Cited by 906 · cited 1× · see citing works

The antidepressant fluoxetine restores plasticity in the adult visual cortex

Vetencourt, J. F. M., Sale, A., Viegi, A., Baroncelli, L., De Pasquale, R., F. O'Leary, O., Castrén, E., & Maffei, L. (2008) · Science · doi:10.1126/science.1150516 · Cited by 890 · see citing works

Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala

Miserendino, M. J. D., Sananes, C. B., Melia, K. R., & Davis, M. (1990) · Nature · doi:10.1038/345716a0 · Cited by 824 · see citing works

Facilitation of Conditioned Fear Extinction by Systemic Administration or Intra-Amygdala Infusions of d-Cycloserine as Assessed with Fear-Potentiated Startle in Rats

Walker, D. L., Ressler, K. J., Lu, K.-T., & Davis, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02343.2002 · Cited by 815 · see citing works

Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment

Warner‐Schmidt, J. L., & Duman, R. S. (2006) · Hippocampus · doi:10.1002/hipo.20156 · Cited by 787 · see citing works

Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex

Radley, J. J., Sisti, H. M., Hao, J., Rocher, A. B., McCall, T., Hof, P. R., McEwen, B. S., & Morrison, J. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.01.006 · Cited by 769 · see citing works

Reduced Glial Cell Density and Neuronal Size in the Anterior Cingulate Cortex in Major Depressive Disorder

Cotter, D., Mackay, D., Landau, S., Kerwin, R., & Everall, I. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.545 · Cited by 766 · see citing works

Memory traces unbound

Nader, K. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)00042-5 · Cited by 763 · see citing works

Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine

Robinson, T. E., & Kolb, B. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08491.1997 · Cited by 704 · see citing works

Role of neurotrophic factors in depression

CASTREN, E., VOIKAR, V, & RANTAMAKI, T. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.009 · Cited by 667 · see citing works

Glycine and N-Methyl-d-Aspartate Receptors: Physiological Significance and Possible Therapeutic Applications

Danysz, W., & Parsons, C. G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01382-6 · Cited by 649 · see citing works

The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior

Schmidt, H. D., & Duman, R. S. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282ee2aa8 · Cited by 649 · see citing works

Gliogenesis and Glial Pathology in Depression

Rajkowska, G., & Miguel-Hidalgo, J. J. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707780619326 · Cited by 612 · see citing works

Disruption of reconsolidation but not consolidation of auditory fear conditioning by noradrenergic blockade in the amygdala

Dębiec, J., & Ledoux, J. E. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.018 · Cited by 602 · see citing works

Augmentation of Exposure Therapy With D-Cycloserine for Social Anxiety Disorder

Hofmann, S. G., Meuret, A. E., Smits, J. A. J., Simon, N. M., Pollack, M. H., Eisenmenger, K., Shiekh, M., & Otto, M. W. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.298 · Cited by 560 · cited 1× · see citing works

Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder

Brunet, A., Orr, S. P., Tremblay, J., Robertson, K., Nader, K., & Pitman, R. K. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.05.006 · Cited by 548 · see citing works

Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear

Bredy, T. W., Wu, H., Crego, C., Zellhoefer, J., Sun, Y. E., & Barad, M. (2007) · Learning & Memory · doi:10.1101/lm.500907 · Cited by 548 · see citing works

Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction

Goldman-Rakic, P., Castner, S., Svensson, T., Siever, L., & Williams, G. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1793-y · Cited by 544 · see citing works

Chronic stress alters synaptic terminal structure in hippocampus

Magariños, A. M., Verdugo, J. M. G., & McEwen, B. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.14002 · Cited by 543 · see citing works

A Guide to Treatments That Work

Treasure, J. L. (2001) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(00)00040-1 · Cited by 535 · see citing works

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

Krystal, J. H., D'Souza, D. C., Mathalon, D., Perry, E., Belger, A., & Hoffman, R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1582-z · Cited by 530 · see citing works

A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy

Norberg, M. M., Krystal, J. H., & Tolin, D. F. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.012 · Cited by 510 · see citing works

Stress and Plasticity in the Limbic System

Sapolsky, R. M. (2003) · Neurochemical Research · doi:10.1023/a:1026021307833 · Cited by 489 · see citing works

Alprazolam and Exposure Alone and Combined in Panic Disorder with Agoraphobia: A Controlled Study in London and Toronto

Marks, I. M., Swinson, R. P., Başoǧlu, M., Kuch, K., Noshirvani, H., O'Sullivan, G., Lelliott, P. T., Kirby, M., McNamee, G., Sengun, S., et al. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.6.776 · Cited by 478 · see citing works

VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants

Warner-Schmidt, J. L., & Duman, R. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610282104 · Cited by 438 · see citing works

Astroglial Plasticity in the Hippocampus is Affected by Chronic Psychosocial Stress and Concomitant Fluoxetine Treatment

Czéh, B., Simon, M., Schmelting, B., Hiemke, C., & Fuchs, E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300982 · Cited by 434 · see citing works

Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression

Eisch, A. J., Bolaños, C. A., de Wit, J., Simonak, R. D., Pudiak, C. M., Barrot, M., Verhaagen, J., & Nestler, E. J. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.003 · Cited by 420 · see citing works

The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments

Buchanan, R. W., Javitt, D. C., Marder, S. R., Schooler, N. R., Gold, J. M., McMahon, R. P., Heresco-Levy, U., & Carpenter, W. T. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06081358 · Cited by 419 · see citing works

Is it time to reassess the BDNF hypothesis of depression?

Groves, J. O. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002075 · Cited by 403 · see citing works

Reversal of Antipsychotic-Induced Working Memory Deficits by Short-Term Dopamine D1 Receptor Stimulation

Castner, S. A., Williams, G. V., & Goldman, P. S. (2000) · Science · doi:10.1126/science.287.5460.2020 · Cited by 401 · see citing works

Memory reconsolidation mediates the strengthening of memories by additional learning

Lee, J. L. C. (2008) · Nature Neuroscience · doi:10.1038/nn.2205 · Cited by 398 · see citing works

Effects of D-cycloserine on extinction of conditioned freezing.

Ledgerwood, L., Richardson, R., & Cranney, J. (2003) · Behavioral Neuroscience · doi:10.1037/0735-7044.117.2.341 · Cited by 388 · see citing works

D-Cycloserine Augmented Exposure Therapy for Obsessive-Compulsive Disorder

Kushner, M. G., Kim, S. W., Donahue, C. B., THURAS, P. D., Adson, D. E., Kotlyar, M., McCabe, J., Peterson, J., & Foa, E. B. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.020 · Cited by 384 · see citing works

Augmentation of Behavior Therapy With <scp>d</scp> -Cycloserine for Obsessive-Compulsive Disorder

Wilhelm, S., Buhlmann, U., Tolin, D. F., Meunier, S. A., Pearlson, G. D., Reese, H. E., Cannistraro, P., Jenike, M. A., & Rauch, S. L. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07050776 · Cited by 358 · see citing works

Neurochemical Sensitization in the Pathophysiology of Schizophrenia: Deficits and Dysfunction in Neuronal Regulation and Plasticity

Lieberman, J., Sheitman, B., & Kinon, B. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00045-6 · Cited by 355 · see citing works

Stress blunts serotonin- and hypocretin-evoked EPSCs in prefrontal cortex: Role of corticosterone-mediated apical dendritic atrophy

Liu, R.-J., & Aghajanian, G. K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706679105 · Cited by 346 · see citing works

Chronic Unpredictable Stress Decreases Cell Proliferation in the Cerebral Cortex of the Adult Rat

Banasr, M., Valentine, G. W., Li, X., Gourley, S. L., Taylor, J. R., & Duman, R. S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.02.006 · Cited by 341 · see citing works

A Randomized Controlled Trial of D-Cycloserine Enhancement of Exposure Therapy for Social Anxiety Disorder

Guastella, A. J., Richardson, R., Lovibond, P. F., Rapee, R. M., Gaston, J. E., Mitchell, P., & Dadds, M. R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.11.011 · Cited by 326 · see citing works

Low-frequency repetitive transcranial magnetic stimulation improves intractable epilepsy

Tergau, F., Naumann, U., Paulus, W., & Steinhoff, B. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01301-x · Cited by 317 · see citing works

Auditory hallucinations: a review of psychological treatments

Shergill, S. S., Murray, R. M., & McGuire, P. K. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00052-8 · Cited by 313 · cited 1× · see citing works

d-Cycloserine: A ligand for the coupled glycine receptor has partial agonist characteristics

Hood, W. F., Compton, R. P., & Monahan, J. B. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90379-0 · Cited by 309 · see citing works

Modeling Sensitization to Stimulants in Humans: An [ ¹¹ C]Raclopride/Positron Emission Tomography Study in Healthy Men

Boileau, I., Dagher, A., Leyton, M., Gunn, R. N., Baker, G. B., Diksic, M., & Benkelfat, C. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.12.1386 · Cited by 305 · see citing works

Transcranial magnetic stimulation and auditory hallucinations in schizophrenia

Hoffman, R. E., Boutros, N. N., Hu, S., Berman, R., Krystal, J. H., & Charney, D. S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02043-2 · Cited by 303 · see citing works

Basolateral amygdala noradrenergic influence enables enhancement of memory consolidation induced by hippocampal glucocorticoid receptor activation

Roozendaal, B., Nguyen, B. T., Power, A. E., & McGaugh, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11642 · Cited by 293 · see citing works

Slow Transcranial Magnetic Stimulation, Long-Term Depotentiation, and Brain Hyperexcitability Disorders

Hoffman, R. E., & Çavuş, I. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1093 · Cited by 286 · see citing works

Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample

Hoffman, R. E., Gueorguieva, R., Hawkins, K. A., Varanko, M., Boutros, N. N., Wu, Y.-T., Carroll, K., & Krystal, J. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.041 · Cited by 272 · see citing works

Excitatory-inhibitory balance and critical period plasticity in developing visual cortex

Hensch, T. K., & Fagiolini, M. (2005) · Progress in Brain Research · doi:10.1016/s0079-6123(04)47009-5 · Cited by 267 · see citing works

Reduction of human visual cortex excitability using 1-Hz transcranial magnetic stimulation

Boroojerdi, B., Prager, A., Muellbacher, W., & Cohen, L. G. (2000) · Neurology · doi:10.1212/wnl.54.7.1529 · Cited by 256 · see citing works

Double-Blind, Placebo-Controlled, Crossover Trial of Glycine Adjuvant Therapy for Treatment-Resistant Schizophrenia

Heresco‐Levy, U., Javitt, D. C., Ermilov, M., Mordel, C., Horowitz, A., & Kelly, D. (1996) · The British Journal of Psychiatry · doi:10.1192/bjp.169.5.610 · Cited by 255 · see citing works

Efficacy of D-Cycloserine for Enhancing Response to Cognitive-Behavior Therapy for Panic Disorder

Otto, M. W., Tolin, D. F., Simon, N. M., Pearlson, G. D., Basden, S., Meunier, S. A., Hofmann, S. G., Eisenmenger, K., Krystal, J. H., & Pollack, M. H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.036 · Cited by 251 · see citing works

Pharmacotherapy to prevent PTSD: Results from a randomized controlled proof‐of‐concept trial in physically injured patients

Stein, M. B., Kerridge, C., Dimsdale, J. E., & Hoyt, D. B. (2007) · Journal of Traumatic Stress · doi:10.1002/jts.20270 · Cited by 249 · see citing works

The histone deacetylase inhibitor valproic acid enhances acquisition, extinction, and reconsolidation of conditioned fearPreprint

Bredy, T. W., & Barad, M. (2008) · Learning & Memory · doi:10.1101/lm.801108 · Cited by 248 · see citing works

Long-Term Plasticity of Visually Evoked Potentials in Humans is Altered in Major Depression

Normann, C., Schmitz, D., Fürmaier, A., Döing, C., & Bach, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.10.006 · Cited by 243 · see citing works

Crossed reduction of human motor cortex excitability by 1-Hz transcranial magnetic stimulation

Wassermann, E. M., Wedegaertner, F. R., Ziemann, U., George, M. S., & Chen, R. E. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00437-6 · Cited by 234 · see citing works

NMDA Agonists and Antagonists as Probes of Glutamatergic Dysfunction and Pharmacotherapies in Neuropsychiatric Disorders

Krystal, J. H., D’Souza, C., Petrakis, I. L., Belger, A., Berman, R., Charney, D. S., Abi‐Saab, W., & Madonick, S. H. (1999) · Harvard Review of Psychiatry · doi:10.3109/hrp.7.3.125 · Cited by 232 · see citing works

N-Methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives

Millan, M. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2199-1 · Cited by 226 · see citing works

High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia

Heresco-Levy, U., Ermilov, M., Lichtenberg, P., Bar, G., & Javitt, D. C. (2004) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00707-8 · Cited by 222 · see citing works

Noradrenergic Signaling in the Amygdala Contributes to the Reconsolidation of Fear Memory

Dębiec, J., & LeDoux, J. E. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1364.056 · Cited by 221 · see citing works

Modulating Neural Networks With Transcranial Magnetic Stimulation Applied Over the Dorsal Premotor and Primary Motor Cortices

Chouinard, P. A., van der Werf, Y. D., Leonard, G. T., & Paus, T. (2003) · Journal of Neurophysiology · doi:10.1152/jn.01105.2002 · Cited by 211 · see citing works

Bidirectional synaptic plasticity in intercalated amygdala neurons and the extinction of conditioned fear responses

Royer, S., & Paré, D. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00455-4 · Cited by 210 · see citing works

Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis

Tuominen, H. J., Tiihonen, J., & Wahlbeck, K. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.05.005 · Cited by 209 · see citing works

Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments

Piccinni, A., Marazziti, D., Catena, M., Domenici, L., Debbio, A. D., Bianchi, C., Mannari, C., Martini, C., Pozzo, E. D., Schiavi, E., et al. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.05.005 · Cited by 206 · see citing works

Synaptic integration and plasticity of new neurons in the adult hippocampus

Ge, S., Sailor, K. A., Ming, G., & Song, H. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.155655 · Cited by 206 · see citing works

Long-Lasting Psychotomimetic Consequences of Repeated Low-Dose Amphetamine Exposure in Rhesus Monkeys

Castner, S. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00050-5 · Cited by 187 · see citing works

Cognitive Remediation and Vocational Rehabilitation for Schizophrenia

Wexler, B. E. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi038 · Cited by 178 · see citing works

Molecular mechanisms of neuroplasticity and pharmacological implications: the example of tianeptine

McEwen, B. S., & Chattarji, S. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.09.008 · Cited by 174 · see citing works

d-Cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed inXenopus oocytes

Watson, G. B., Bolanowski, M. A., Baganoff, M. P., Deppeler, C. L., & Lanthorn, T. H. (1990) · Brain Research · doi:10.1016/0006-8993(90)90745-w · Cited by 172 · see citing works

Probing the pathophysiology of auditory/verbal hallucinations by combining functional magnetic resonance imaging and transcranial magnetic stimulation

Hoffman, R. E., Hampson, M., Wu, K., Anderson, A. W., Gore, J. C., Buchanan, R. J., Constable, R. T., Hawkins, K. A., Sahay, N., & Krystal, J. H. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhl183 · Cited by 169 · see citing works

Role of NMDA receptors and MAP kinase in the amygdala in extinction of fear: clinical implications for exposure therapy*

Davis, M. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02138.x · Cited by 154 · see citing works

Parametrically Dissociating Speech and Nonspeech Perception in the Brain Using fMRI

Benson, R. R., Whalen, D. H., Richardson, M. L., Swainson, B., Clark, V. P., Lai, S., & Liberman, A. M. (2001) · Brain and Language · doi:10.1006/brln.2001.2484 · Cited by 154 · see citing works

Enhancement of Working Memory in Aged Monkeys by a Sensitizing Regimen of Dopamine D 1 Receptor Stimulation

Castner, S. A., & Goldman, P. S. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3987-03.2004 · Cited by 147 · see citing works

Effects of multiple exposures to d-cycloserine on extinction of conditioned fear in rats

Parnas, A. S., Weber, M. F., & Richardson, R. (2005) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2005.01.001 · Cited by 146 · see citing works

Prevention of stress-induced morphological and cognitive consequences

McEwen, B. S., Conrad, C. D., Kuroda, Y., Frankfurt, M., Magariños, A. M., & McKittrick, C. R. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00064-3 · Cited by 137 · see citing works

Subunit specificity and mechanism of action of NMDA partial agonist d-cycloserine

Sheinin, A., Shavit, S., & Benveniste, M. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00073-9 · Cited by 136 · see citing works

Plasma Brain-Derived Neurotrophic Factor as a Peripheral Marker for the Action Mechanism of Antidepressants

Lee, H.-Y., & Kim, Y.-K. (2008) · Neuropsychobiology · doi:10.1159/000149817 · Cited by 132 · see citing works

Allosteric modulation of NMDA receptor via elevation of brain glycine and d-serine: The therapeutic potentials for schizophrenia

Yang, C. R., & Svensson, K. A. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.004 · Cited by 129 · see citing works

Electroconvulsive Seizure Treatment Increases Cell Proliferation in Rat Frontal Cortex

Madsen, T. M., Yeh, D. D., Valentine, G. W., & Duman, R. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300565 · Cited by 124 · see citing works

Repetitive Transcranial Magnetic Stimulation as a Neuropsychiatric Tool

Post, R. M., Kimbrell, T. A., McCann, U. D., Dunn, R. T., Osuch, E. A., Speer, A. M., & Weiss, S. R. B. (1999) · Journal of Ect · doi:10.1097/00124509-199903000-00005 · Cited by 114 · see citing works

Effects of Repetitive Transcranial Magnetic Stimulation on Movement-related Cortical Activity in Humans

Rossi, S. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.8.802 · Cited by 112 · see citing works

IV glycine and oral d-cycloserine effects on plasma and CSF amino acids in healthy humans

D’Souza, D. C., Gil, R. B., Cassello, K., Morrissey, K., Abi‐Saab, D., White, J., Sturwold, R., Bennett, A., Karper, L. P., Zuzarte, E., et al. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00133-x · Cited by 111 · see citing works

Actions of ?-cycloserine at the ? glycine receptor site in vivo

Emmett, M. R. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90161-4 · Cited by 108 · see citing works

Long‐term potentiation as a substrate for memory: Evidence from studies of amygdaloid plasticity and Pavlovian fear conditioning

Goosens, K. A., & Maren, S. (2002) · Hippocampus · doi:10.1002/hipo.10099 · Cited by 104 · see citing works

Increasing the Levels of Insulin-Like Growth Factor-I by an IGF Binding Protein Inhibitor Produces Anxiolytic and Antidepressant-Like Effects

Malberg, J. E., Platt, B., Rizzo, S. J. S., Ring, R. H., Lucki, I., Schechter, L. E., & Rosenzweig-Lipson, S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301358 · Cited by 101 · see citing works

Is the glycine site half saturated or half unsaturated? Effects of glutamatergic drugs in schizophrenia patients

Javitt, D. C. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000214340.14131.bd · Cited by 85 · see citing works

Improved cognitive function in schizophrenia after one year of cognitive training and vocational services

Greig, T. C., Zito, W., Wexler, B. E., Fiszdon, J. M., & Bell, M. D. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.07.003 · Cited by 82 · see citing works

Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients

Başterzi, A. D., Yazıcı, K. U., Aslan, E., Delıalıoğlu, N., Taşdelen, B., Acar, Ş. T., & Yazıcı, A. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.016 · Cited by 80 · see citing works

Durability of cognitive remediation training in schizophrenia: performance on two memory tasks at 6-month and 12-month follow-up

Fiszdon, J. M., BRYSON, G. J., Wexler, B. E., & Bell, M. D. (2003) · Psychiatry Research · doi:10.1016/j.psychres.2003.10.004 · Cited by 77 · see citing works

Propranolol for reemergent posttraumatic stress disorder following an event of retraumatization: A case study

Taylor, F., & Cahill, L. F. (2002) · Journal of Traumatic Stress · doi:10.1023/a:1020145610914 · Cited by 68 · see citing works

Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex

Castner, S. A., Vosler, P. S., & Goldman‐Rakic, P. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.019 · Cited by 66 · see citing works

Amphetamine‐Induced Glutamate Efflux in the Rat Ventral Tegmental Area Is Prevented by MK‐801, SCH 23390, and Ibotenic Acid Lesions of the Prefrontal Cortex

Wolf, M. E., & Xue, C. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731529.x · Cited by 65 · see citing works

Effects of beta blockade, PTSD diagnosis, and explicit threat on the extinction and retention of an aversively conditioned response.

Orr, S., Milad, M., Metzger, L., Lasko, N., Gilbertson, M., & Pitman, R. (2006) · Biological Psychology · doi:10.1016/j.biopsycho.2006.05.001 · Cited by 63 · see citing works

Amphetamine Sensitization Alters Dendritic Morphology in Prefrontal Cortical Pyramidal Neurons in the Non-Human Primate

Selemon, L. D., Begović, A., Goldman‐Rakic, P. S., & Castner, S. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301179 · Cited by 58 · see citing works

Glycine Site Agonists of the NMDA Receptor: A Review

D’Souza, D. C., Charney, D. S., & Krystal, J. H. (1995) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1995.tb00285.x · Cited by 57 · see citing works

Emerging role of the FGF system in psychiatric disorders

Riva, M. A., Molteni, R., Bedogni, F., Racagni, G., & Fumagalli, F. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.03.001 · Cited by 52 · see citing works

Dinapsoline: Characterization of a D1 Dopamine Receptor Agonist in a Rat Model of Parkinson's Disease

Gulwadi, A. G., Korpinen, C. D., Mailman, R. B., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38751-8 · Cited by 48 · see citing works

Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.

Lin, C. W., Bianchi, B., Miller, T. R., et al. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12376-8 · Cited by 45 · see citing works

Can Cognitive Behavioral Therapy Reduce Relapse Rates of Depression After ECT? A Preliminary Study

Fenton, L. R., Fasula, M. K., Ostroff, R. B., et al. (2006) · Journal of Ect · doi:10.1097/01.yct.0000235201.42287.b4 · Cited by 41 · see citing works

Neuroplasticity as a Target for the Pharmacotherapy of Psychiatric Disorders: New Opportunities for Synergy with Psychotherapy

Krystal, J. H. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.08.017 · Cited by 34 · see citing works

From vice to virtue: Insights from sensitization in the nonhuman primate

Castner, S. A., & Williams, G. V. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.026 · Cited by 34 · see citing works

Behavioral effects of orally administered glycine in socially housed monkeys chronically treated with phencyclidine

Linn, G. S., O’Keeffe, R. T., Lifshitz, K., Schroeder, C. E., & Javitt, D. C. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0771-6 · Cited by 28 · see citing works

1983 Annual meeting of the Society of Biological Psychiatry

(1983) · Journal of Affective Disorders · doi:10.1016/0165-0327(83)90014-9 · Cited by 19 · see citing works

Tolerance to the procholinergic action of the D1 receptor full agonist dihydrexidine

Wade, M. R., & Nomikos, G. G. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0106-4 · Cited by 10 · see citing works

Psychedelics promote structural and functional neural plasticity

Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., Burbach, K. F., Soltanzadeh Zarandi, S., Sood, A., Paddy, M. R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.022 · Cited by 1,207 · see citing works

The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity

Castrén, E., & Rantamäki, T. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20758 · Cited by 864 · see citing works

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

Vollenweider, F. X., & Kometer, M. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2884 · Cited by 723 · see citing works

Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond

Krystal, J. H., Sanacora, G., & Duman, R. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.026 · Cited by 406 · see citing works

Trauma Reactivation Under the Influence of Propranolol Decreases Posttraumatic Stress Symptoms and Disorder: 3 Open-Label Trials

Brunet, A., Poundja, J., Tremblay, J., Bui, É., Thomas, É., Orr, S. P., Azzoug, A., Birmes, P., & Pitman, R. K. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318222f360 · Cited by 331 · see citing works

Pharmacological Treatment of Obsessive-Compulsive Disorder

Pittenger, C., & Bloch, M. H. (2014) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2014.05.006 · Cited by 222 · see citing works

Neuronal network plasticity and recovery from depression

Castrén, E. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1 · Cited by 190 · see citing works

Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists

Krystal, J. H., Mathew, S. J., DʼSouza, D. C., Garakani, A., Gunduz-Bruce, H., & Charney, D. S. (2010) · CNS Drugs · doi:10.2165/11533230-000000000-00000 · Cited by 180 · see citing works

Aerobic Exercise as a Tool to Improve Hippocampal Plasticity and Function in Humans: Practical Implications for Mental Health Treatment

Kandola, A., Hendrikse, J., Lucassen, P. J., & Yücel, M. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00373 · Cited by 155 · see citing works

Synaptic Loss and the Pathophysiology of PTSD: Implications for Ketamine as a Prototype Novel Therapeutic

Krystal, J. H., Abdallah, C. G., Averill, L. A., Kelmendi, B., Harpaz-Rotem, I., Sanacora, G., Southwick, S. M., & Duman, R. S. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0829-z · Cited by 145 · see citing works

Neural mechanisms underlying heterogeneity in the presentation of anxious temperament

Shackman, A. J., Fox, A. S., Oler, J. A., Shelton, S. E., Davidson, R. J., & Kalin, N. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214364110 · Cited by 113 · see citing works

Psychedelic therapy's transdiagnostic effects: A research domain criteria (RDoC) perspective

Kelly, J. R., Gillan, C. M., Prenderville, J., Kelly, C., Harkin, A., Clarke, G., & O'Keane, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.800072 · Cited by 69 · see citing works

Central amygdala nucleus (Ce) gene expression linked to increased trait-like Ce metabolism and anxious temperament in young primates

Fox, A. S., Oler, J. A., Shelton, S. E., Nanda, S. A., Davidson, R. J., Roseboom, P. H., & Kalin, N. H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206723109 · Cited by 57 · see citing works

Pharmacotherapy for anxiety disorders in children and adolescents

Kodish, I., Rockhill, C., & Varley, C. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.4/ikodish · Cited by 62 · see citing works

Sertraline May Improve Language Developmental Trajectory in Young Children with Fragile X Syndrome: A Retrospective Chart Review

Indah Winarni, T., Chonchaiya, W., Adams, E., Au, J., Mu, Y., Rivera, S. M., Nguyen, D. V., & Hagerman, R. J. (2012) · Autism Research and Treatment · doi:10.1155/2012/104317 · Cited by 52 · see citing works

Lääkehoitosuunnitelma Sotkanhelmen vanhainkodille

Kärkkäinen, J. (2012) · Theseus (Ammattikorkeakoulujen)

Behavior Therapy and Pharmacotherapy for Obesity

Craighead, L. W. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780320043003 · Cited by 165 · see citing works

Progress on strategies of rational medication in older adults

Dai, M. (2016) · Zhonghua laonian yixue zazhi · doi:10.3760/cma.j.issn.0254-9026.2016.01.025

The value of cognitive behavioral therapy on quality of life in addition to pharmacotherapy in adults with ADHD

Wettstein, R., Klabbers, Y., Romijn, E., et al. (2022) · European Psychiatry · doi:10.1192/j.eurpsy.2022.1564

Pharmacotherapy

Yu, S. P., & Day, R. O. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99269-5.00006-2 · Cited by 3 · see citing works